Use of targeted therapies for advanced renal cell carcinoma in the Veterans Health Administration

BACKGROUND: The objective of this study is to describe the use of targeted therapies for the treatment of advanced renal cell carcinoma (RCC) and overall survival (OS) among patients in clinical practice in the Veterans Health Administration (VHA). METHODS: A retrospective cohort of 286 patients fro...

Descripción completa

Detalles Bibliográficos
Autores principales: Aspinall, Sherrie L., Zhao, Xinhua, Geraci, Mark C., Good, Chester B., Cunningham, Francesca E., Heron, Bernadette B., Becker, Daniel, Lee, Steve, Prasad, Vinay
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Clinical Cancer Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6825975/
https://www.ncbi.nlm.nih.gov/pubmed/31536684
http://dx.doi.org/10.1002/cam4.2531

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6825975/
https://www.ncbi.nlm.nih.gov/pubmed/31536684
http://dx.doi.org/10.1002/cam4.2531

Ejemplares similares